Overview

Trial of SAVVY Vaginal Gel and HIV in Nigeria

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
Female
Summary
Heterosexual contact is now the primary route of transmission for HIV worldwide. This study is a phase 3 trial designed to determine the effectiveness and safety of the 1.0% C31G (SAVVY) vaginal gel for the prevention of male-to-female transmission of HIV among women at high risk.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Biosyn
Collaborators:
FHI 360
United States Agency for International Development (USAID)
Criteria
Inclusion Criteria:

- 18 to 35 year old women

- HIV negative

- More than one sexual partner in past 3 months

- Average 3 coital acts per week

- Willing to use vaginal gel and condoms for 12 months

Exclusion Criteria:

- HIV positive

- Pregnant